|
MechanismGlycoprotein B of human cytomegalovirus inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhaseIND Approval |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Shenzhen Zhixin Biotechnology Co., Ltd.
0 Patents (Medical) associated with Shenzhen Zhixin Biotechnology Co., Ltd.
100 Deals associated with Shenzhen Zhixin Biotechnology Co., Ltd.
100 Translational Medicine associated with Shenzhen Zhixin Biotechnology Co., Ltd.